Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

IR Thematic call on dupilumab

October 01, 2016

Sanofi and Regeneron hosted a conference call for the financial community focusing on investigational dupilumab following the late breaking data presentation from two trials evaluating dupilumab for inadequately controlled moderate-to-severe atopic dermatitis (SOLO 1 and SOLO 2) at the 25th European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria.

 

The presentation was followed by a Q&A session.

 

Related Press releases

 

Right area:

Stock Market

IR mobile application

SANOFI IR - The Investor Relations Mobile Application

Download SANOFI IR on smartphone and tablet!

 

Your services